263 related articles for article (PubMed ID: 24623100)
1. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals.
Fenzl A; Itariu BK; Kosi L; Fritzer-Szekeres M; Kautzky-Willer A; Stulnig TM; Kiefer FW
Diabetologia; 2014 Jun; 57(6):1204-8. PubMed ID: 24623100
[TBL] [Abstract][Full Text] [Related]
2. Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Hu FB; Behbehani K; Elkum N
Sci Rep; 2015 Jun; 5():10949. PubMed ID: 26077345
[TBL] [Abstract][Full Text] [Related]
3. Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.
Guo K; Lu J; Yu H; Zhao F; Pan P; Zhang L; Chen H; Bao Y; Jia W
Obesity (Silver Spring); 2015 Apr; 23(4):793-7. PubMed ID: 25776943
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
[TBL] [Abstract][Full Text] [Related]
5. Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescents.
Tuhan H; Abacı A; Anık A; Çatlı G; Küme T; Çalan ÖG; Acar S; Böber E
Diabetes Res Clin Pract; 2016 Apr; 114():37-42. PubMed ID: 27103367
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients.
Hu H; Sun W; Yu S; Hong X; Qian W; Tang B; Wang D; Yang L; Wang J; Mao C; Zhou L; Yuan G
Diabetes Care; 2014 Oct; 37(10):2718-22. PubMed ID: 25024395
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients.
Wang L; Song J; Wang C; Lin P; Liang K; Sun Y; He T; Li W; Zhao R; Qin J; Lu Y; Liu J; Liu F; Hou X; Chen L
J Diabetes Res; 2016; 2016():2616539. PubMed ID: 26649318
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes.
Espes D; Lau J; Carlsson PO
Diabetologia; 2014 Jan; 57(1):50-3. PubMed ID: 24078058
[TBL] [Abstract][Full Text] [Related]
9. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.
Chen X; Lu P; He W; Zhang J; Liu L; Yang Y; Liu Z; Xie J; Shao S; Du T; Su X; Zhou X; Hu S; Yuan G; Zhang M; Zhang H; Liu L; Wang D; Yu X
J Clin Endocrinol Metab; 2015 Jan; 100(1):E96-100. PubMed ID: 25303484
[TBL] [Abstract][Full Text] [Related]
10. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters.
Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS
J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786
[TBL] [Abstract][Full Text] [Related]
11. Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women.
Barja-Fernández S; Folgueira C; Seoane LM; Casanueva FF; Dieguez C; Castelao C; Agüera Z; Baños R; Botella C; de la Torre R; Fernández-García JC; Fernández-Real JM; Frühbeck G; Gómez-Ambrosi J; Jiménez-Murcia S; Tinahones FJ; Estivill X; Fernández-Aranda F; Nogueiras R
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1188-96. PubMed ID: 26171798
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
[TBL] [Abstract][Full Text] [Related]
13. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes.
Gómez-Ambrosi J; Pascual E; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2004-9. PubMed ID: 25050901
[TBL] [Abstract][Full Text] [Related]
14. Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention.
Roth CL; Elfers C; Lass N; Reinehr T
Pediatr Diabetes; 2017 Sep; 18(6):485-491. PubMed ID: 27402552
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.
Wu S; Gao H; Ma Y; Fu L; Zhang C; Luo X
Pediatr Diabetes; 2016 Feb; 17(1):53-60. PubMed ID: 25413012
[TBL] [Abstract][Full Text] [Related]
16. Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans.
Gómez-Ambrosi J; Pascual-Corrales E; Catalán V; Rodríguez A; Ramírez B; Romero S; Vila N; Ibáñez P; Margall MA; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2016 Oct; 101(10):3803-3811. PubMed ID: 27472196
[TBL] [Abstract][Full Text] [Related]
17. Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.
Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A; Saleem TH
BMC Endocr Disord; 2020 Sep; 20(1):145. PubMed ID: 32988370
[TBL] [Abstract][Full Text] [Related]
18. Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus.
Hassan AB; Salih SF; Hassan II; Saadi FS; Abdulah DM; Ahmed IH; Taher SM; Khaleel BB
Diabetes Metab Syndr; 2019; 13(1):458-463. PubMed ID: 30641744
[TBL] [Abstract][Full Text] [Related]
19. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
